New study aims to unlock secrets of rare childhood eye disease
NCT ID NCT06273748
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking 290 children with non-infectious chronic uveitis, a rare eye inflammation that can cause vision loss. Researchers will collect data on symptoms, lab results, and complications over several years. The goal is to better understand the disease and identify risk factors for severe outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand and manage pediatric uveitis, potentially improving treatment guidelines and outcomes for children.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may take years and might not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 290 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2022
- Expected to finish
-
May 2032
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The data of patients who have been under the care of the hospital since 2010 will be included, and new patients diagnosed from the date of Ethical Committee approval onwards for the next 10 years will also be included
- Ages
-
1 year to 16 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * diagnosis of non-infectious chronic uveitis before the age of 16; * signed informed consent form. Exclusion Criteria: * Patients with a diagnosis of infectious uveitis * history of malignant pathology, * history of demyelinating pathology, * history of cerebral vasculitis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Uveitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
19 sites in 5 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
- UOSD Reumatologia Pediatrica Dipartimento di Salute della Donna e del Bambino Azienda Ospedale Università di Padova
NOT_YET_RECRUITINGPadova, Italy
-
ATTIKON General Hospital
RECRUITINGAthens, 12462, Greece
-
Children's Mercy Kansas City Division of Rheumatology, Division of Rheumatology
RECRUITINGKansas City, Kansas, 64108, United States
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45207, United States
-
Clinica Pediatrica, IRCCS Policlinico San Matteo
NOT_YET_RECRUITINGPavia, Italy
-
Department of Medical of Health Sciences, Magna Grecia University
RECRUITINGCatanzaro, Italy
-
Department of Pediatric Rheumatology, Kocaeli University,
RECRUITINGKocaeli, Turkey (Türkiye)
-
Department of Pediatrics, Giovanni XXIII Pediatric Hospital, University of Bari
NOT_YET_RECRUITINGBari, Italy
-
Dipartimento di Immunologia e Reumatologia Pediatrica, Ospedale Vito Fazzi
RECRUITINGLecce, Italy
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico SC Pediatria e Immunoreumatologia PI
RECRUITINGMilan, Italy
-
IRCCS Ospedale Pediatrico Bambino Gesù Dipartimento Reumatologia
NOT_YET_RECRUITINGRoma, Italy
-
IRCCS materno infantile Burlo Garofolo
RECRUITINGTrieste, Italy
-
Meyer Children's Hospital IRCCS
RECRUITINGFlorence, Firenze, Italy
-
Ospedale Spedali Civili di Brescia
NOT_YET_RECRUITINGBrescia, Italy
-
Santa Maria Goretti Hospital
NOT_YET_RECRUITINGRoma, Italy
-
The Children's Hospital Corporation d/b/a Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
-
Unità di Immunologia e Reumatologia, Ospedale Pediatrico Regina Margherita, AOU Città della Salute e della scienza di Torino
NOT_YET_RECRUITINGTorino, Italy
-
Unità di Reumatologia ed Immunologia Pediatrica dell'Ospedale Fatebenefratelli Sacco di Milano
NOT_YET_RECRUITINGMilan, Italy
-
University fo Gent
NOT_YET_RECRUITINGGhent, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a biologic combo match steroids for uveitis?
- Can a High-Speed eye scan catch silent blinding disease in kids?
- A simple blood draw might reveal hidden eye lymphoma
- Can a new pill tame eye inflammation when others fail?
- Could a simple blood test allow uveitis patients to safely take less medication?
- New DNA test could revolutionize diagnosis of eye infections